Primary idiopathic hypertrophic osteoarthropathy in a child: characteristics of the disease with a case report

The paper gives the data available in the literature on the relatively rare disease hypertrophic osteoarthropathy (HOA). This syndrome includes symptoms, such as clubbed fingers (hypertrophy of the distal phalanges), periostosis (subperiosteal new bone formation along the distal diaphysis of the long bones with further progression in the proximal direction) and arthritis, as well as skin changes (pachydermia) that are not an obligate sign. There is information concerning the pathogenesis, clinical, laboratory, and instrumental manifestations of this disease. The paper describes a clinical case of primary HOA in a teenager who has been misdiagnosed with juvenile idiopathic arthritis (JIA). It shows the necessity of including HOA in the spectrum of differential diagnosis in children with articular involvement since HOA may resemble JIA in its clinical manifestations. Patients with primary HOA who have been misdiagnosed with JIA have a long ineffective experience with immunosuppressive and sometimes even glucocorticoid therapies. The specific features that can distinguish the full form of primary HOA from chronic arthritis is the absence of inflammatory changes in the synovial fluid, the presence of clubbed fingers, pachydermia and the lack of morning stiffness.

1. Fauci AS, Braunwald E, Kasper DL, et al, editors. Harrison's Principles of Internal Medicine. New York: McGraw-Hill Medical; 2008. 2650 p.

2. Hippocrene Books. Hippocrates: Prognostic: Regimen in Acute Diseases, Sacred Disease, Art, Breaths, Law, Decorum, Physician, Dentition (Loeb Classical Library). London, UK: Harvard University Press; 1849; Vol 1.

3. Manger B, Lindner A, Manger K, et al. [Hypertrophic osteoarthropathy. Bamberger-Marie disease]. Z Rheumatol. 2011;70(7): 554-60. doi: 10.1007/s00393-011-0813-7.

4. Touraine A, Solente G, Gole L. Un syndrome osteodermopathique: La pachydermie plicaturee avec pachyperiostose des extremites. Presse Med. 1935;43:1820-4.

5. Poormoghim H, Hosseynian A, Javadi A. Primary hypertrophic osteoarthropathy. Rheumatol Int. 2012;32(3):607-10.

6. doi: 10.1007/s00296-010-1667-z.

7. Martinez-Lavin M, Vargas A, Rivera-Vinas M. Hypertrophic osteoarthropathy: a palindrome with a pathogenic connotation. Curr Opin Rheumatol. 2008;20(1):88-91. doi: 10.1097/BOR. 0b013e3282f14a5a.

8. Narayanan S, Mohamed Gani VM, Sundararaju V. Primary hypertrophic osteoarthropathy with hypertrophic gastropa-thy. J Clin Rheumatol. 2010;16(4):190-2. doi: 10.1097/RHU.0b013e3181e04d80.

9. Martinez-Lavin M, Pineda C, Valdez T, et al. Primary hypertrophic osteoarthropathy. Semin Arthritis Rheum. 1988;17(3):156-62. doi: 10.1016/0049-0172(88)90017-0.

10. Karnan S, Krishnamoorthy V, Ethiraj P, Sathyanathan BP. Touraine-Solente-Gole syndrome: The complete form needs to be recognized. Indian J Nucl Med. 2012; 27(3):201-4.

11. Kumar S, Sidhu S, Mahajan BB. Touraine-soulente-golе syndrome: a rare case report and review of the literature. Ann Dermatol. 2013;25(3):352-5. doi: 10.5021/ad. 2013.25.3.352.

12. Castori M, Sinibaldi L, Mingarelli R, et al. Pachydermoperiostosis: an update. Clin Genet. 2005;68(6):477-86. doi:10.1111/j.1399-0004.2005.00533.x.

13. Nguyen S, Hojjati M. Review of current therapies for secondary hypertrophic pulmonary osteoarthropathy. Clin Rheumatol. 2011;30(1):7-13. doi: 10.1007/s10067-010-1563-7.

14. Martinez-Lavin M. Digital clubbing and hypertrophic osteoarthropathy: a unifying hypothesis. J Rheumatol. 1987;14(1):6-8.

15. Ginsburg J, Brown JB. Increased oestrogen excretion in hypertrophic pulmonary osteoarthropathy. Lancet. 1961;2(7215): 1274-6. doi: 10.1016/S0140-6736(61)91139-4.

16. Schumacher HR Jr. Articular manifestations of hypertrophic pulmonary osteoarthropathy in bronchogenic carcinoma. Arthritis Rheum. 1976;19(3):629-36.

17. doi: 10.1002/art.1780190317.

18. Matucci-Cerinic M, Martinez-Lavin M, Rojo F, et al. von Willebrand factor antigen in hypertrophic osteoarthropathy. J Rheumatol. 1992;19(5):765-7.

19. Martinez-Lavin M. Hypertrophic osteoarthropathy. Curr Opin Rheumatol. 1997;9(1):83-6. doi: 10.1097/00002281-199701000-00016.

20. Martinez-Ferrer A, Peris P, Alos L, et al. Prostaglandin E2 and bone turnover markers in the evaluation of primary hypertrophic osteoarthropathy (pachydermoperiostosis): a case report. Clin Rheumatol. 2009;28(10): 1229-33. doi: 10.1007/s10067-009-1197-9.

21. Da Costa FV, de Magalhaes Souza F, Sonia C, et al. Infliximab treatment in pachydermoperiostosis: a rare disease without an effective therapeutic option. J Clin Rheumatol. 2010;16(4):183-4. doi: 10.1097/RHU. 0b013e3181df91c6.

22. Kabashima K, Sakabe J, Yoshiki R, et al. Involvement of Wnt signaling in dermal fibroblasts. Am J Pathol. 2010;176(2):721-32. doi: 10.2353/ajpath.2010.090454.

23. Sasaki T, Niizeki H, Shimizu A, et al. Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype-genotype correlation in Japanese patients with pachydermoperiosto-sis. J Dermatol Sci. 2012;68(1):36-44. doi: 10.1016/j.jdermsci.2012.07.008.

24. Zhang Z, He JW, Fu WZ, et al. Two novel mutations in the SLCO2A1 gene in a Chinese patient with primary hypertrophic osteoarthropathy. Gene. 2014;534(2):421-3. doi: 10.1016/j.gene.2013.10.051.

25. Cheng R, Li M, Guo Y, et al. Three novel mutations in the SLCO2A1 gene in two Chinese families with primary hypertrophic osteoarthropathy. Eur J Dermatol. 2013; 23(5):636-9.

26. Toovey OT, Eisenhauer HJ. A new hypothesis on the mechanism of digital clubbing secondary to pulmonary pathologies. Med Hypotheses. 2010;75(6):511-3.

27. doi: 10.1016/j.mehy.2010.07.009.

28. Altman RD, Tenenbaum J. Hypertrophic osteoarthropathy. In: Kelley W, Harris ED Jr, Ruddy S, Sledge C, editors. Textbook of Rheumatology. 5th ed. Philadelphia, Pa: WB Saunders; 1997. P. 1514-20.

29. Swartz MH. Textbook of Physical Diagnosis: History and Examination. 2nd ed.Philadelphia, Pa: WB Saunders; 1994. P. 76-8.

30. Padula SJ, Broketa G, Sampieri A, et al. Increased collagen synthesis in skin fibroblasts from patients with primary hyper-trophic osteoarthropathy. Evidence for trans-activational regulation of collagen transcription. Arthritis Rheum. 1994;37(9):1386-94. doi: 10.1002/art.1780370918

31. Bigler FC. The morphology of clubbing. Am J Pathol. 1958;34(2):237-61.

32. Rothschild BM, Rothschild C. Recognition of hypertrophic osteoarthropa-thy in skeletal remains. J Rheumatol. 1998; 25(11):2221-7.

33. Altman RD. Hypertrophic osteoarthropa-thy. In: McCarty JD, Koopman WJ, editors. Arthritis and Allied Conditions. 12th ed.Philadelphia, Pa: Lea & Febiger; 1993. P. 1511-7.

34. Pineda C, Fonseca C, Martinez-Lavin M. The spectrum of soft tissue and skeletal abnormalities of hypertrophic osteoarthropa-thy. J Rheumatol. 1990;17(5):626-32.

35. Pineda CJ, Guerra J Jr, Weisman MH,

36. et al. The skeletal manifestations of clubbing: a study in patients with cyanotic congenital heart disease and hypertrophic osteoarthropa-thy. Semin Arthritis Rheum. 1985;14(4): 263-73. doi: 10.1016/0049-0172(85)90045-9

37. Martinez-Lavin M. Hypertrophic osteoarthropathy. In: Klippel JH, Dieppe PA, editorss. Rheumatology. 2nd ed. London, UK: Mosby; 1998. P. 8.46.1-4.

38. Resnick D. Enostosis, hyperostosis, and periostitis. In: Resnick D, Kransdorf MJ, editors. Bone and Joint Imaging. 3rd ed. Philadelphia, Pa: Elsevier Saunders; 2005. P. 1433-5.

39. Fam AG, Chin-Sang H, Ramsay CA. Pachydermoperiostosis: scintigraphic, thermographic, plethysmographic, and capillaroscopic observations. Ann Rheum Dis. 1983;42(1):98-102. doi: 10.1136/ard.42.1.98.

40. Lauter SA, Vasey FB, Hü ttner I, Osterland CK. Pachydermoperiostosis: studies on the synovium. J Rheumatol. 1978;5(1):85-95.

41. Weinstein RS, Roberson PK, Manolagas SC. Giant osteoclast formation and longterm oral bisphosphonate therapy. N Engl J Med. 2009;360(1):53-62. doi: 10.1056/ NEJMoa0802633.

42. Beckenbach L, Baron JM, Merk HF, et al. Retinoid treatment of skin diseases. Eur J Dermatol. 2015;25(5):384-91.

43. Birch E, Jenkins D, Noble S. Treatment of painful hypertrophic osteoarthropathy associated with non-small cell lung cancer with octreotide: a case report and review of the literature. BMJ Support Palliat Care. 2011;1(2):189-92. doi: 10.1136/bmjspcare-2011-000052.